Patients with myelodysplastic syndromes (MDS) often mobilise abnormal haemopoietic progenitors.

被引：0
|
作者：
Mijovic, A [1 ]
Howard, J [1 ]
Czepulkowski, B [1 ]
Pagliuca, A [1 ]
Mufti, GJ [1 ]
机构：
[1] Univ London Kings Coll Hosp, London, England
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
502
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [1] In vitrodevelopment of haemopoietic progenitors in myelodysplastic syndromes (MDS)
    S Tauro
    DT Bowen
    SJL Brada
    JThM de Wolf
    DW Hendriks
    JW Smit
    E Vellenga
    Leukemia, 1999, 13 : 494 - 495
  • [2] In vitro development of haemopoietic progenitors in myelodysplastic syndromes (MDS)
    Tauro, S
    Bowen, DT
    LEUKEMIA, 1999, 13 (03) : 494 - 495
  • [3] In vitro development of haemopoietic progenitors in myelodysplastic syndromes (MDS) -: Response
    Brada, SJL
    de Wolf, JTM
    Hendriks, DW
    Smit, JW
    Vellenga, E
    LEUKEMIA, 1999, 13 (03) : 495 - 495
  • [4] Do patients with low-grade myelodysplastic syndrome (MDS) mobilise normal hemopoietic progenitors?
    Mijovic, A
    Delforge, M
    Sekhavat, M
    Czepulkowski, B
    Ghulam, MJ
    BLOOD, 2000, 96 (11) : 149A - 149A
  • [5] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Iannella, E.
    Levi, A.
    Natalino, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2007, 31 : S107 - S107
  • [6] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Napoleone, L.
    Vozella, F.
    Levi, A.
    Natalino, E.
    Alimena, G.
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1605 - 1607
  • [7] CD34 positive progenitors can be cytogenetically normal in patients with myelodysplastic syndromes (MDS).
    Abruzzese, E
    Radford, JE
    Pettenati, MJ
    Rao, PN
    Hurd, DD
    Rainer, RO
    Powell, BL
    Torti, FM
    BLOOD, 1996, 88 (10) : 1906 - 1906
  • [8] Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2022, 14 (08)
  • [9] INTENSIVE CHEMOTHERAPY FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    BERNSTEIN, SH
    BRUNETTO, VL
    DAVEY, FR
    MAYER, RJ
    WURSTERHILL, D
    SCHIFFER, CA
    BLOOMFIELD, CD
    BLOOD, 1993, 82 (10) : A196 - A196
  • [10] Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report
    Liu, Cong
    Zou, Cuicui
    Zou, Shuhui
    Wang, Qun
    Xiao, Dejun
    Zhang, Liqin
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (02) : 206 - 210
12345